SAGILITYNSEQ1 FY26July 30, 2025

SAGILITY LIMITED

2,849words
4turns
0analyst exchanges
0executives
Key numbers — 40 extracted
₹ 15,389 million
e been made from time to time by or on behalf of the company.. 2 Q1 FY26 Performance Highlights ₹ 15,389 million ₹ 3,687 million ₹ 1,997 million Headcount 39,917 ► 17.9% Y-o-Y organic growth in Q1 FY26 driv
₹ 3,687 million
ime to time by or on behalf of the company.. 2 Q1 FY26 Performance Highlights ₹ 15,389 million ₹ 3,687 million ₹ 1,997 million Headcount 39,917 ► 17.9% Y-o-Y organic growth in Q1 FY26 driven by expansion fr
₹ 1,997 million
on behalf of the company.. 2 Q1 FY26 Performance Highlights ₹ 15,389 million ₹ 3,687 million ₹ 1,997 million Headcount 39,917 ► 17.9% Y-o-Y organic growth in Q1 FY26 driven by expansion from existing clie
17.9%
Performance Highlights ₹ 15,389 million ₹ 3,687 million ₹ 1,997 million Headcount 39,917 ► 17.9% Y-o-Y organic growth in Q1 FY26 driven by expansion from existing clients, while new wins are exp
25.8%
xisting clients, while new wins are expected to further strengthen momentum in FY26 Y-o-Y growth 25.8% 23.1 % at Constant Currency Organic Y-o-Y growth 17.9% 15.4 % at Constant Currency Margin % 24
23.1 %
g clients, while new wins are expected to further strengthen momentum in FY26 Y-o-Y growth 25.8% 23.1 % at Constant Currency Organic Y-o-Y growth 17.9% 15.4 % at Constant Currency Margin % 24.0% Ma
15.4 %
then momentum in FY26 Y-o-Y growth 25.8% 23.1 % at Constant Currency Organic Y-o-Y growth 17.9% 15.4 % at Constant Currency Margin % 24.0% Margin % 13.0% Clinicians & Technology heads 3200+ ► $32
24.0%
8% 23.1 % at Constant Currency Organic Y-o-Y growth 17.9% 15.4 % at Constant Currency Margin % 24.0% Margin % 13.0% Clinicians & Technology heads 3200+ ► $32 M (potential steady state ACV) of new
13.0%
stant Currency Organic Y-o-Y growth 17.9% 15.4 % at Constant Currency Margin % 24.0% Margin % 13.0% Clinicians & Technology heads 3200+ ► $32 M (potential steady state ACV) of new business & expa
26.5%
ion won in Q1 FY26 ► Expansion and new SOWs from 18 existing clients in Q1 FY26 Y-o-Y growth % 26.5% Y-o-Y growth % 38.0% Attrition* 27.6% ► 4 new clients onboarded in Q1 ► Helping set-up a GCC f
38.0%
Expansion and new SOWs from 18 existing clients in Q1 FY26 Y-o-Y growth % 26.5% Y-o-Y growth % 38.0% Attrition* 27.6% ► 4 new clients onboarded in Q1 ► Helping set-up a GCC for a client on a BOT mo
27.6%
SOWs from 18 existing clients in Q1 FY26 Y-o-Y growth % 26.5% Y-o-Y growth % 38.0% Attrition* 27.6% ► 4 new clients onboarded in Q1 ► Helping set-up a GCC for a client on a BOT model ► Operations
Guidance — 1 items
Note
opening
Borrowing doesn’t include accrued interest 13 Q1 FY26 Consolidated Profit and Loss Amt in INR M Particulars Q4 FY25 Q1 FY26 Q1 FY25 Revenue from Operation Employee benefits expense* Other expenses^ Adjusted EBITDA** Adjusted EBITDA %
Risks & concerns — 2 flagged
Minimal impact of drop in Membership ► Increase in outsourcing by Payers & Providers to manage costs.
Note
Rising Medicare utilization rates impacting profitability ► This is expected to strain Payer margins; ► Increase in outsourcing to manage costs better; however, CMS increased MA payments by 5.06% for CY2026 however, pricing pressure to increase ► Strong tailwinds for higher outsourcing in clinical segment Tariffs ► Likely tariff driven increase in cost of ► No tangible impact imported medical equipment & Pharmaceuticals.
Note
Speaking time
Note
2
Adjustments
2
Opening remarks
Note
Adjusted EBITDA represents EBITDA adjusted for earnouts payable under the acquisition agreements (DCI, BirchAI & BroadPath), share-based payment awards and exclude other income (including forex gain/loss). *Voluntary attrition (considering employees who were employees for more than 90 days) on an annualized basis Quarterly KPIs Revenue from Operation (in INR Million) 15,389 15,685 12,233 25.8% Q1 FY26 Q4 FY25 Q1 FY25 YoY% Revenue by Vertical Split By Payer % By Provider % 88.4% 11.6% 89.7% 10.3% 89.1% 10.9% Growth in revenue from operation (%) 25.8% 22.2% 9.6% Adjusted EBITDA (in INR Million) Adjusted EBITDA % Adjusted PAT (in INR Million) Adjusted PAT % 3,687 24.0% 1,997 13.0% 4,176 26.6% 2,398 15.3% 2,916 23.8% 1,447 11.8% 26.5% 38.0% Total Number of Employees 39,917 39,409 35,858 11.3% Voluntary attrition rate* (%) 27.6% 32.5% 27.3%
Note
Adjusted EBITDA represents EBITDA adjusted for earnouts payable under acquisition agreements (DCI, BirchAI & BroadPath), share-based payment awards and exclude other income (including forex gain/loss). Voluntary attrition (considering employees who were employees for more than 90 days) on an annualized basis 4 Annual KPIs Number of Client groups* Active Number of new client addition (Gross) Delivery sites Number of delivery sites New site addition (Gross) Client groups contribution to revenues Top 3 Client % Top 5 Client % Top 10 Client % Number of Million-dollar client groups Number of clients contributing more than US$20 million Number of clients contributing to US$5 - US$20 million Number of clients contributing to US$1 - US$5 million Number of clients contributing less than US$1 million * Client groups comprise client entities together with their affiliates. Q1 FY26 FY25 FY24 FY23 77 4 33 2 75 38 33 10 44 13 30 4 35 7 27 2 TTM Jun 25 FY25 FY24 FY23 64.7% 76.3% 89.4% 7 6 17 47 66.2%
Adjustments
M&A Earnouts SAR (stock appreciation right) – Non Cash Other Income^^ Forex Gain / (Loss) Reported EBITDA Finance costs Depreciation and amortisation Profit Before Tax Tax Expenses Reported Profit After Tax EPS Adjusted PAT Adjusted PAT % Adjusted EPS (Rs) 15,389 15,685 12,233 9,646 2,056 3,687 24.0% 155 71 50 49 3,560 274 1,182 2,104 618 1,486 0.32 1,997 13.0% 0.43 9,429 2,079 4,176 26.6% 207 104 101 -135 3,832 298 1,143 2,390 564 1,826 0.39 2,398 15.3% 0.51 7,527 1,790 2,916 23.8% 124 852 35 209 2,184 374 1,100 710 487 223 0.05 1,447 11.8% 0.33 ► Q1 26 Organic Revenue at INR 14,429 Mn (YoY% 17.9% and 15.4% at constant currency YoY%) YoY% 25.8% QoQ% -1.9% 26.5% -11.7% 63.0% -7.1% 196.3% -12.0% 566.4% 530.0% 38.0% -18.6% -18.6% -16.7% 30.5% -16.7% *Employee benefits expense excludes M&A earnout and SAR (shown separately under adjustments), ^ Other expenses exclude forex loss. ^^ Other income excludes forex gain. Forex Gain and Forex Loss clubbed together and shown separately. ** Adjust
Adjustments
M&A Earnouts SAR (stock appreciation right) – Non Cash Other Income^^ Forex Gain / (Loss) Reported EBITDA Finance costs Depreciation and amortisation Profit Before Tax Tax Expenses Reported Profit After Tax EPS Adjusted PAT Adjusted PAT % Adjusted EPS (Rs) 11,161 6,361 1,881 2,919 26.2% 282 0 15 100 2,751 471 1,661 619 194 425 0.10 1,424 12.8% 0.33 Q2 FY24 Q3 FY24 Q4 FY24 Q1 FY25 Q2 FY25 Q3 FY25 Q4 FY25 Q1 FY26 10,941 12,602 12,832 12,233 13,250 14,531 15,685 15,389 6,674 1,795 2,472 22.6% 132 0 98 193 2,632 483 1,715 434 84 350 0.08 1,254 11.5% 0.29 7,912 1,789 2,901 23.0% 71 0 -8 -164 2,659 468 1,756 435 -271 706 0.16 1,567 12.4% 0.37 7,925 1,764 3,143 24.5% 70 0 8 38 3,119 429 1,760 929 127 802 0.19 1,651 12.9% 0.39 7,527 1,790 2,916 23.8% 124 852 35 209 2,184 374 1,100 710 487 223 0.05 1,447 11.8% 0.33 7,912 1,874 3,465 26.1% 120 93 153 -241 3,165 297 1,264 1,604 431 1,173 0.25 1,636 12.3% 0.35 8,415 1,988 4,127 28.4% 120 85 99 341 4,362 302 1,162 2,898 729 2,169 0.46 2,626 18.1% 0
← All transcriptsSAGILITY stock page →